Immunyx Pharma vs Impact Biotech
Immunyx Pharma vs Impact Biotech, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Immunyx Pharma is on 46/100 and Impact Biotech on 39/100.
Where each one leads
Immunyx Pharma
- our overall score: 46/100 against 39/100
- agent readiness: 41/100 against 21/100
Impact Biotech
- domain rating: 19/100 against 6/100
- headcount: 42 against 6
- headcount growth: +16.9% against +6.0%
- LinkedIn following: 1,470 against 858
At a glance
| Measure | Immunyx Pharma | Impact Biotech |
|---|---|---|
| What it is | Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases. | Develops and launches Padeliporfin VTP therapy for solid tumor treatment. |
| Category | Life Sciences, Biopharmaceutical, Drug Development, Biotech | Life Sciences, Cancer, Therapeutics, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Software |
| Founded | 2017 | 1996 |
| Headquarters | New York, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Immunyx Pharma | Impact Biotech |
|---|---|---|
| Employees | 6 | 42 |
| Headcount growthLast 12 months | +6.0% | +16.9% |
| Total funding | Not published | $2.7M |
| Latest round | Not published | Grant |
| LinkedIn followers | 858 | 1,470 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Immunyx Pharma | Impact Biotech |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 46/100 | 39/100 |
| Traction | 8/100 | 49/100 |
| Team | 60/100 | Not published |
| Search visibility | 32/100 | 34/100 |
| Quality | 58/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (41/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 6/100 | 19/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Immunyx Pharma | Impact Biotech |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery |
| Analytics | Not detected | Google Analytics 4 |
Immunyx Pharma vs Impact Biotech: common questions
Which is better, Immunyx Pharma or Impact Biotech?
On our 0-100 score Immunyx Pharma rates higher (46/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Immunyx Pharma and Impact Biotech compare on the numbers?
Immunyx Pharma leads on our overall score (46/100 against 39/100), agent readiness (41/100 against 21/100). Impact Biotech leads on domain rating (19/100 against 6/100), headcount (42 against 6), headcount growth (+16.9% against +6.0%), LinkedIn following (1,470 against 858).
Read the full Immunyx Pharma review and pricing or the Impact Biotech review and pricing. You can also browse other Immunyx Pharma alternatives we track.